News

Podcast

Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS

Author(s):

Pearl Steinzor

Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.

Nathan Walcker

Nathan Walcker

Florida Cancer Specialists & Research Institute's (FCS') Nathan Walcker, CEO, discusses some key strategic practices and initiatives in providing high quality community-based oncology care he has implemented at FCS.

He spoke with us at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event held in Tampa, Florida, on August 10, 2023.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify


Related Videos
Lalan Wilfong, MD, during a video interview
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel
dr ken cohen
Ana Baramidze, MD, PhD
Eva Otter, president of PHA Europe
Samyukta Mullangi, MD, MBA.
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine, The University of Manchester
Wanda Phipatanakul, MD, MS, professor of pediatrics, Harvard Medical School; director of the Clinical Research Center, Boston Children's Hospital
Io Hui, PhD, researcher at The University of Edinburgh
Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital
Related Content
Collaboration is key | image credit: Prostock-studio - stock.adobe.com
September 11th 2024

Collaboration Is Key: Dr Matthew Smeltzer Explores Quality-of-Care Improvement in NSCLC

Kyle Munz
Matthew Smeltzer, PhD, University of Memphis, shares insights into his team's quality-of-care initiative to identify and combat gaps in care for patients with early-stage non–small cell lung cancer (NSCLC).
Providing Patients a Voice in Their Recovery
September 9th 2024

Providing Patients a Voice in Their Recovery

Maggie L. Shaw
September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this second episode, we speak with Rebekah Sedlock, DSW, LCSW, and Mandy Fauble, PhD, LCSW.
While shares varied by payer market, 73.6% of retail prescriptions overall were attributed to CVS Caremark, Optum Rx, and Express Scripts in the study. | Image credit: DedMityay - stock.adobe.c
September 10th 2024

A Highly Concentrated PBM Market Highlights Need for Policy Changes

Rose McNulty
The findings may help inform policy changes at the federal level aiming to address unfair and deceptive pharmacy benefit manager (PBM) practices.
Combatting the Opioid Epidemic: Insights From the Front Lines
September 2nd 2024

Combatting the Opioid Epidemic: Insights From the Front Lines

Maggie L. Shaw
September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this first episode, we speak with Michael Lynch, MD, associate professor of emergency medicine at the University of Pittsburgh and an attending emergency physician and medical toxicologist at the University of Pittsburgh Medical Center.
Diverse representation in health care materials is one of multiple factors that could benefit patient education initiatives | image credit: Fitry - stock.adobe.come
September 10th 2024

Different Options for Different People: Dr Bellinda King-Kallimanis Explores the State of Patient Education in Lung Cancer

Kyle Munz
Bellinda King-Kallimanis, PhD, LUNGevity Foundation, reflects on her experiences in patient-focused research to discuss the current state of patient education, the importance of patient advocates, and mediating barriers to health care access.
Lung shaped pond in forest | Image Credit: © malp - stock.adobe.com
September 10th 2024

Beyond Smoking, Lung Cancer Drivers Include Pollution and Genetics

Christina Mattina
Lung cancer is tied to tobacco smoking in the public consciousness, but a significant proportion of cases are driven by factors like indoor and outdoor air pollution or ancestral genetic variants.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo